Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T18:05:47.749Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:05:47.749Z.

Quote observation: 2026-10-06T18:00:08.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 412,299,249
Total debt · period ending 2026-06-30: 4,255,000
Cash · period ending 2026-06-30: 16,317,000
TTM free cash flow · period ending 2026-06-30: -43,704,000

FMP input reference: f7c009322a229257a98230f40e2740bea1b73477c063b99c175921fa35d9c923

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

SRTA EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

EV/FCF RATIO AVG TTM

N/A

EV/FCF RATIO AVG 3Y

N/A

EV/FCF RATIO AVG 5Y

N/A

EV/FCF RATIO AVG 10Y

N/A

EV/FCF RATIO AVG 15Y

N/A

EV/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SRTA Competitors' EV/FCF Ratio

SRTA

Strata Critical Medical, Inc.

Current

Market Cap

$412.30M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MYGN

Myriad Genetics, Inc.

vs SRTA

Market Cap

$412.90M

EV/FCF Ratio

N/A

TTM Avg

3927.74x

3Y Avg

907.14x

5Y Avg

462.84x

SENS

Senseonics Holdings, Inc.

vs SRTA

Market Cap

$413.34M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SI

Shoulder Innovations, Inc.

vs SRTA

Market Cap

$409.37M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RZLT

Rezolute, Inc.

vs SRTA

Market Cap

$408.76M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EIKN

Eikon Therapeutics, Inc. Common Stock

vs SRTA

Market Cap

$408.45M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CARL

Carlsmed, Inc.

vs SRTA

Market Cap

$407.13M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NGNE

Neurogene Inc.

vs SRTA

Market Cap

$406.20M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AVIR

Atea Pharmaceuticals, Inc.

vs SRTA

Market Cap

$404.94M

EV/FCF Ratio

N/A

TTM Avg

5.74x

3Y Avg

5.74x

5Y Avg

5.74x

SPRY

ARS Pharmaceuticals, Inc.

vs SRTA

Market Cap

$422.04M

EV/FCF Ratio

N/A

TTM Avg

98.46x

3Y Avg

98.46x

5Y Avg

98.46x

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Strata Critical Medical, Inc. (SRTA)	$412.30M	N/A	N/A	N/A	N/A
Myriad Genetics, Inc. (MYGN)vs ›	$412.90M	N/A	3927.74x	907.14x	462.84x
Senseonics Holdings, Inc. (SENS)vs ›	$413.34M	N/A	N/A	N/A	N/A
Shoulder Innovations, Inc. (SI)vs ›	$409.37M	N/A	N/A	N/A	N/A
Rezolute, Inc. (RZLT)vs ›	$408.76M	N/A	N/A	N/A	N/A
Eikon Therapeutics, Inc. Common Stock (EIKN)vs ›	$408.45M	N/A	N/A	N/A	N/A
Carlsmed, Inc. (CARL)vs ›	$407.13M	N/A	N/A	N/A	N/A
Neurogene Inc. (NGNE)vs ›	$406.20M	N/A	N/A	N/A	N/A
Atea Pharmaceuticals, Inc. (AVIR)vs ›	$404.94M	N/A	5.74x	5.74x	5.74x
ARS Pharmaceuticals, Inc. (SPRY)vs ›	$422.04M	N/A	98.46x	98.46x	98.46x

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

SRTA EV/FCF Ratio History

DATE	EV/FCF RATIO
2020-11-10	194.28x
2020-11-09	194.28x
2020-11-06	194.68x
2020-11-05	194.68x
2020-11-04	194.68x
2020-11-03	194.68x
2020-11-02	193.69x
2020-10-30	193.69x
2020-10-29	195.07x
2020-10-28	195.07x
2020-10-27	195.07x
2020-10-26	195.27x
2020-10-23	195.47x
2020-10-22	195.47x
2020-10-21	195.47x
2020-10-20	195.47x
2020-10-19	195.47x
2020-10-16	195.47x
2020-10-15	195.47x
2020-10-14	195.86x
2020-10-13	195.67x
2020-10-12	196.06x
2020-10-09	196.06x
2020-10-08	195.86x
2020-10-07	197.15x
2020-10-06	197.25x
2020-10-05	196.86x
2020-10-02	196.86x
2020-10-01	199.03x
2020-09-30	196.66x
2020-09-29	197.85x
2020-09-28	197.65x
2020-09-25	197.65x
2020-09-24	197.65x
2020-09-23	197.65x
2020-09-22	197.65x
2020-09-21	197.65x
2020-09-18	197.85x
2020-09-17	197.65x
2020-09-16	197.65x
2020-09-15	197.65x
2020-09-14	197.65x
2020-09-11	197.45x
2020-09-10	197.25x
2020-09-09	197.25x
2020-09-08	196.66x
2020-09-04	197.25x
2020-09-03	195.67x
2020-09-02	196.26x
2020-09-01	196.26x
2020-08-31	194.87x
2020-08-28	195.47x
2020-08-27	194.68x
2020-08-26	197.25x
2020-08-25	196.26x
2020-08-24	196.26x
2020-08-21	196.26x
2020-08-20	196.06x
2020-08-19	195.86x
2020-08-18	197.25x
2020-08-17	197.65x
2020-08-14	197.65x

EV/FCF Ratio: N/A

SRTA EV/FCF Ratio Chart

SRTA EV/FCF Ratio Metrics

SRTA Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

SRTA EV/FCF Ratio History

Related Metrics